Andrew Andersen

was that just on casualty? Or perhaps you could update us on how you're thinking about property demand into midyear?

Are you still seeing rate ahead of loss cost?

Do you still see returns of kind of 20% here on this line? And how are you thinking about ILS impacting kind of return levels and industry capital?

Can you just provide us with your latest view on loss trends?

some mortgage associations are talking about originations picking up in '26. Are you kind of thinking about that as we turn to next year?

is full year '24 still a good way to think about the rest of the year for the OpEx? Or is there still some head count costs coming on?

on the income from operating affiliates, I think it was $17 million in the quarter. It was down a bit year-over-year.

You'd mentioned deploying capital into London specialty markets. I would have thought that scenario where perhaps a bit more competition has come in

The the other specialty line, I realize there's probably a number of different businesses in here, but it declined in the quarter.

Just looking at the underlying results in North America Commercial, they seem pretty strong. Is there an opportunity to take more business net here?

whether that's coming from existing synergy buckets simply proving larger than expected or entirely new sources

how you are able to capture these market share gains or maybe the exposure growth underlying it?

it does seem to be coming in a little bit over the past few quarters, and I think part of the idea with AP was it would give you access to some new M&A pipeline

as you think about the AP synergies in '26, is that including both revenue—I guess, that's included both revenue and expense synergies

I think you've talked about international a bit as maybe being additive or incremental. I guess if I look at some international retail, U.K., Canada, Australia and New Zealand, it's kind of been li...

in the past, we've talked about maybe 6% organic underlying expansion of 60 bps or so. How should we think of maybe the sensitivity there if that growth is being led by specialty

I think I heard you say 5% organic in reinsurance, and that's relative to some really strong quarters in recent history

I think in the script, you mentioned some early AI successes. Could you maybe elaborate a bit on those

within specialty, could you maybe talk about the growth difference between open brokerage and MGA

The supplemental commissions within Brokerage were pretty strong. Was there any timing benefit there

there's been some broader industry discussion around broker commissions and fee levels. How are you thinking about this dynamic

On expanding mandates versus truly new logos, can you maybe just talk about what the mix was this quarter

as we kind of shift towards '26, how are you kind of seeing the reinsurance pricing environment? And maybe just some color on demand changes?

Health Solutions, 6% organic, really strong and has been for a couple of years now. You listed a few drivers there of the organic input positive market impact

on the slides, you had mentioned that future M&A could primarily focus on specialty businesses.

is there a scenario where you actually have a margin benefit as you're not incurring the comp and ben costs, but you are keeping the revenues?

if there's an effort to replace these folks' kind of quickly, is that strategy kind of contemplated here?

Could you maybe just talk about what you're seeing in terms of rate? Is there any bottoming going on there?

how long do you usually find it takes to get those acquired entities to target levels?

should we think about the underlying reinsurance accident year loss ratio perhaps trending a bit lower

how you determine what kind of casualty you see to the sidecar and what you retain on your own balance sheet

how much incremental demand are you seeing at an industry level? And how are you considering Everest deployment there

are you seeing any improvement in terms that could warrant reengagement down the line?

What are you kind of seeing in the pricing environment on casualty reinsurance and your go-forward view

I think you did mention some movement on casualty reinsurance this quarter. Could you just expand a bit on what

Were they maybe a little bit lumpier this quarter? And perhaps you could just talk about how you're thinking

Over the next kind of 1 to 2 years, should we think of that 6% staying in place

can you maybe just talk about the competitive market there, because it seems like it is getting increasingly competitive

just talk about the opportunity within Florida at midyear and how you're thinking about growth

What have you learned maybe about the frequency or severity of this product relative to the traditional auto book?

Can you maybe just talk about what you're seeing in reserves to release some this quarter

And which acquisition channels are contributing the most to incremental growth today, whether that be direct or cross sales?

Where specifically are you seeing some savings today? And how much of that is being reinvested versus dropping through?

on the auto waitlist, 700,000, I'm not too familiar with what exactly this metric is

Can you maybe just expand on technology development spend? It was kind of flattish year-over-year and lower as a percentage of premium earned

Looking within the Property segment, I think you've made a note that like 30% of that business is going direct now.

how many quarters or periods would it have to take before you would kind of be allowed to reflect that in a rate filing

Could you maybe talk about any changes you're seeing in bundle rates?

On the $10 million R&D spend that you had discussed, could you talk about maybe more specifically where you're allocating that and how you're thinking about a payback period on that?

within the partnership channel, could you talk about just the growth there? Is that being driven by increased production from some of the larger relationships? Or are you seeing more meaningful con...

just how should we think about PIF growth trending relative to guidance you had given last quarter of full year PIF acceleration?

how do you think about the OpEx leverage, specifically on G&A and tech spend, so not looking at the marketing and other expense line item

Maybe you could just talk about how that opportunity came to be and just the overall level of competitiveness you're seeing on the direct channel?

Can you maybe just talk about the change that you saw in severity this quarter, and if it requires any change to rate here?

how do you think about the relative attractiveness of workers’ comp from either a growth or a margin perspective

within surety, growth accelerated again. How would you frame the demand conditions relative to credit quality

how much of the auto book is open for new business and how much of the homeowners' book

how the hit rate or quote to bind improvement has been in lines where you have lowered price

are the standard national carriers may be going deeper into E&S and more into lines of business that have been stickier

To what extent is there an opportunity for that to pick up again, or is there may be a binding constraint here

I think I heard you say 4.6% on the domestic yield book, so maybe some pressure on the Argentina side.

on the D&O market, can you remind us, do you guys focus more on the public or the private

Just on casualty reinsurance, you had mentioned the professional liability component

just on the 50-basis-points impact to current year picks, I know you mentioned it was business mix

Are you seeing any regional divergence in demand trends more broadly or pricing or even any changes in client practices around compensation approaches?

Where do you expect it to show up first, whether it be margin expansion or revenue growth?

how are you thinking about the macro and the demand for project work in 2026? Against some easier first half 2025 comps?

Can we kind of break apart how much you're expecting to come from health care inflation versus new business wins or improving retention?